drugset / Trial / NCT05206500
NextGen - Clinical Implication of Next Generation Sequencing
NaSingle-groupOpen-labelSupportive care
Summary
Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to traditional culture, these techniques have more sensitivity and could potentially be of a great help in patients with Colony Count of less than 10,000 and more than zero.
Timeline
- Start
- 2022-05-17
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Amoxicillin | Other / unclassified | — | — |
| Background | Ampicillin | Unknown | — | — |
| Background | Clindamycin | Unknown | — | — |
| Background | Fosfomycin | Small molecule | — | — |
| Background | Linezolid | Other / unclassified | — | — |
| Background | Metronidazole | Small molecule | — | — |
| Background | Nitrofurantoin | Unknown | — | — |